Bisphosphonates represent 49.4% of drug type sales and hospital pharmacies account for 41.4% within the distribution channel segment in 2026. The anti-osteoporosis fracture healing market is estimated at USD 16.3 billion in 2026, is projected to reach USD 24.5 billion by 2036 and is forecast to post a 4.2% CAGR between 2026 and 2036.